On the contrary, the inhibition of CD38 by boosting NAD+ levels, can improve glucose and lipid metabolism, by protecting against age- and diet-induced diabetes and obesity [37, 38]. Here, CD38 is linked to obesity due to melanocortin 4 receptor deficiency.